Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Multi4 - the first surgical instrument for bladder cancer treatment through a 20-minute outpatient procedure

Project description

New treatment for bladder cancer

Roughly 175 000 Europeans receive a diagnosis of bladder cancer (BC) annually, making it the fifth most prevalent cancer within the EU. The process of diagnosing BC is intricate and time-intensive, while its treatment relies on perilous and antiquated resectoscope surgeries, carrying a substantial risk of recurrence. In this context, the EU-funded Multi4 project strives to introduce the revolutionary Multi4 device and platform. This innovation empowers localised BC treatment through adaptable cystoscopy during the initial consultation with the urologist, encompassing various functions ranging from localised anaesthesia to excising cancerous growths, all within a 20-minute timeframe. The Multi4 groundbreaking technology and its expansion hold the potential to benefit hundreds of thousands of patients.

Objective

Bladder Cancer (BC) is the 5th most common cancer in Europe with the incidence of 175.000 cases annually and has the highest lifetime treatment cost of all cancers. At the diagnostic step, a cystoscope is used. Usually, no biopsies are taken as there are no efficient methods to do so in the outpatient care. If the patient has suspected cancer seen on the monitor, they are scheduled for a surgery. At the surgery step, the biopsies are taken and the cancer is removed using a resectoscope. The procedure is difficult to perform. The instrument used is hard (metal, up to 12 mm in diameter) and inflexible (can damage the urethra). There is a high risk of cancer reseeding elsewhere in the bladder. Up to 75 % of BC patients relapse within 5 years. The related costs in the EU are estimated at € 5 billion annually. No development has taken place since the 1960 when the existing instruments were developed.

We have developed and patented the first medical device (called Multi4) which allows for local treatment of BC through flexible cystoscopy during one visit to the urologist. The instrument has 4 functions:

1. Inject local anaesthesia through a thin needle
2. Pieces of the cancer are cut by the specially coated forceps. Bleeding is stopped immediately.
3. The cancer tissue is automatically transported out through the instrument itself.
4. When the forceps are closed, they become a burning electrode used to burn the surface where the cancer was located and ensure that all cancer cells have been killed.

With the Multi4 platform, the patient can have their cancer treated at the first visit to the urologist. The procedure takes 20 minutes. This technology can thus disrupt the existing healthcare pathways where BC is treated through expensive and complicated surgeries.
The proposed project will develop a go-to-market strategy for this ground-breaking deep tech innovation and empower the female founder to scale the company.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-EIE-2022-SCALEUP-02

See all projects funded under this call

Coordinator

MULTI4 MEDICAL AB
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 75 000,00
Address
BACKALYCKEVAGEN 15
553 13 Jonkoping
Sweden

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Södra Sverige Småland med öarna Jönköpings län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0